NFI Announces Pricing of C$350 million Senior Unsecured Notes Offering and Amendment and Extension of Existing Senior Credit Facilities
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
LONDON und AUSTIN, Texas, 15. Juli 2026 /PRNewswire/ -- Das Jane Goodall Institute (JGI) USA und FormationQ haben heute eine bahnbrechende Forschungspartnerschaft bekannt gegeben, in deren Rahmen die von IonQ entwickelte Quantencomputertechnologie auf Basis gefangener Ionen zur...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Futu Holdings Limited (NASDAQ:FUTU) securities. If you suffered a loss on your Futu Holdings Limited investment and would like to explore a potential recovery under the federal securities laws, Learn about Futu Holdings Limited Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into AstraZeneca PLC ("AstraZeneca PLC") (NYSE:AZN) concerning potential violations of the federal securities laws. AstraZeneca PLC faces a securities investigation after shares fell more than 8.3% in early trading on July 9, 2026. Wainua, a gene-silencing drug for transthyretin-mediated amyloid cardiomyopathy, had been positioned as a key value driver toward AstraZeneca's stated "$80 billion 2030 ambition." The Company referred to the trial as the "largest trial in this population" with the "potential to address key questions" unanswered in the ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ:LCID) securities. If you suffered a loss on your Lucid Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Lucid Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 /WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lucid Group, Inc. (NASDAQ:LCID) between February 25, 2026 and April 13, 2026, inclusive (the "Class Period"), of the important July 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free ..